Indications:
1. For the treatment of influenza A and B in adults and pediatric patients 1 year of age and older. (Oseltamivir phosphate is effective against both influenza A and B; however, clinical data for influenza B are limited). Patients should be treated within 48 hours of symptom onset.
2. For the prophylaxis of influenza A and B in adults and adolescents 13 years of age and older.

Strength:75mg

National Drug Approval Number:H20065415